Schedule 13D ownership disclosure

Amicus Therapeutics Inc

Security class unavailable · CUSIP: 03152W109

Event date: 2021-07-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-048723
Form type
SC 13D
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Feb 22, 2022
Reporting period
Jul 02, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub